TenderAi Logo

Discover the latest tenders, get AI-powered insights, and collaborate to seize government opportunities with TenderAI.

Contact Us

✉️ contact@tenderai.in📞 +91-8448770364

Departments

View All
Department of Military Affairs(90827)
Department of Defence Production(20910)
Indian Railways(14280)
Department of Heavy Industry(10115)
Department of Atomic Energy(10071)

States

View All
MAHARASHTRA(20071)
UTTAR PRADESH(18984)
JAMMU & KASHMIR(12651)
GUJARAT(11830)
KARNATAKA(9749)

Cities

View All
MUMBAI(6104)
BANGALORE(5435)
HYDERABAD(3403)
PUNE(3272)
JAMMU(2591)
Privacy Policy|Terms of Service

© 2025 TenderAI. All rights reserved.

adore medical private limited Tender Performance & Track Record

CIN: U33119RJ2019PTC065484
Active
Private
Company limited by shares

adore medical private limited

Tender Performance & Track Record

CIN: U33119RJ2019PTC065484
Active
Private
Company limited by shares

Company Overview

Summary
ADORE MEDICAL PRIVATE LIMITED Business Analysis Report: Achieving Success in Government Tenders This comprehensive business analysis report delves into the performance of ADORE MEDICAL PRIVATE LIMITED in the realm of government tenders. With a focus on financial performance, competitive positioning, and strategic insights, this report aims to provide a clear understanding of the company's strengths, weaknesses, opportunities, and threats within the Indian government procurement landscape. Key highlights include a 7.8% win rate across 153 bids and securing 12 L1 positions, underscoring their potential and existing foothold in the market.
Primary Ministry: Ministry of Labour and EmploymentPrimary Department: Department of Defence
Founded: 2019State: RAJASTHAN
Primary Ministry:
Ministry of Labour and Employment
Primary Department:
Department of Defence
Founded:2019
State:RAJASTHAN

Tender Performance

Data for 01 April 2024 to 17 June 2025

Live Data

Total Bids / Contract Value

Bids21
Value₹63.77L

Qualified Bids / Q Rate

Bids11
Q Rate52.4%

Total Wins / Win Value

Win1
Value₹29.97L

Wins Rate / Q-W Rate

Rate4.8%
Q-W Rate9.1%

Detailed Performance Analysis

Scroll to view more categories

Tender Performance by Ministries

4 entries

Name

Bids
Value
Qualified
Wins
Value

Ministry of Labour and Employment

0.0% win rate
13
₹8.54 Lakh
7
0
₹0

Ministry of Labour and Employment

Bids
13
₹8.54 Lakh
Qualified
7
Wins
0
₹0
0.0% win rate

Ministry of Defence

0.0% win rate
3
₹22.12 Lakh
0
0
₹0

Ministry of Defence

Bids
3
₹22.12 Lakh
Qualified
0
Wins
0
₹0
0.0% win rate

Ministry of Health and Family Welfare

0.0% win rate
2
₹14K
1
0
₹0

Ministry of Health and Family Welfare

Bids
2
₹14K
Qualified
1
Wins
0
₹0
0.0% win rate

Ministry of Education

0.0% win rate
1
₹11K
1
0
₹0

Ministry of Education

Bids
1
₹11K
Qualified
1
Wins
0
₹0
0.0% win rate

Top Bid Competitors

Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 21 bids — SAXENA ORTHOTIC & PROSTHOSIS CENTER appeared in 13 of them.

Company
Total Bids
Value
Qualified
Rate
Wins
Value

ADORE MEDICAL PRIVATE LIMITED

Your Company
4.8% win rate
21
₹63.77 Lakh
11
52.4%
1
₹29.97 Lakh

ADORE MEDICAL PRIVATE LIMITED

Your Company
Total Bids
21
₹63.77 Lakh
Qualified
11
52.4%
Wins
1
₹29.97 Lakh
4.8% win rate
SAXENA ORTHOTIC & PROSTHOSIS CENTER
38.5% win rate
13
₹29.01 Lakh
8
61.5%
5
₹8.61 Lakh
SAXENA ORTHOTIC & PROSTHOSIS CENTER
Total Bids
13
₹29.01 Lakh
Qualified
8
61.5%
Wins
5
₹8.61 Lakh
38.5% win rate
M/S A K SALES CORPORATION
50.0% win rate
8
₹6.96 Lakh
8
100.0%
4
₹4.77 Lakh
M/S A K SALES CORPORATION
Total Bids
8
₹6.96 Lakh
Qualified
8
100.0%
Wins
4
₹4.77 Lakh
50.0% win rate
NOBLE CURE CO.
71.4% win rate
7
₹22.34 Lakh
5
71.4%
5
₹1.58 Lakh
NOBLE CURE CO.
Total Bids
7
₹22.34 Lakh
Qualified
5
71.4%
Wins
5
₹1.58 Lakh
71.4% win rate
TMT MED SOURCE
6.7% win rate
15
₹30.22 Lakh
15
100.0%
1
₹1.35 Lakh
TMT MED SOURCE
Total Bids
15
₹30.22 Lakh
Qualified
15
100.0%
Wins
1
₹1.35 Lakh
6.7% win rate
NOVOMED INCORPORATION PRIVATE LIMITED
0.0% win rate
9
₹7.06 Lakh
3
33.3%
0
₹0
NOVOMED INCORPORATION PRIVATE LIMITED
Total Bids
9
₹7.06 Lakh
Qualified
3
33.3%
Wins
0
₹0
0.0% win rate
RESMEN SOLUTION
0.0% win rate
8
₹6.96 Lakh
7
87.5%
0
₹0
RESMEN SOLUTION
Total Bids
8
₹6.96 Lakh
Qualified
7
87.5%
Wins
0
₹0
0.0% win rate
SUPREME HEALTHCARE (BANGALORE) PRIVATE LIMITED
0.0% win rate
7
₹4.96 Lakh
1
14.3%
0
₹0
SUPREME HEALTHCARE (BANGALORE) PRIVATE LIMITED
Total Bids
7
₹4.96 Lakh
Qualified
1
14.3%
Wins
0
₹0
0.0% win rate
VEDANSH ENTERPRISES
0.0% win rate
6
₹5.56 Lakh
2
33.3%
0
₹0
VEDANSH ENTERPRISES
Total Bids
6
₹5.56 Lakh
Qualified
2
33.3%
Wins
0
₹0
0.0% win rate
DASS SURGIMED PRIVATE LIMITED
0.0% win rate
5
₹1.58 Lakh
4
80.0%
0
₹0
DASS SURGIMED PRIVATE LIMITED
Total Bids
5
₹1.58 Lakh
Qualified
4
80.0%
Wins
0
₹0
0.0% win rate
OMLITE SCIENTIFIC PRIVATE LIMITED
0.0% win rate
3
₹1.04 Lakh
0
0.0%
0
₹0
OMLITE SCIENTIFIC PRIVATE LIMITED
Total Bids
3
₹1.04 Lakh
Qualified
0
0.0%
Wins
0
₹0
0.0% win rate
Company Profile
CINU33119RJ2019PTC065484
Class
Private
Status
Active
Founded2019

Financial Details

Authorized Capital₹1.0L
Paid-up Capital₹1.0L

Registered Office

PLOT NO.189 A, ROAD NO. 1D VKIANA-JAIPUR-Rajasthan-302013-India

Industry Classification

Manufacturing (Machinery & Equipments)

NIC Code33119

Company Type

CategoryCompany limited by shares
Sub-CategoryNon-government company
Origin
Indian

Market Information

Listing Status
Unlisted
ROCROC Jaipur
Free Trial!

Transform Your Tender Process

Join thousands of businesses winning more tenders

No Credit Card Required
0%
Success Rate
0x
Faster Process
0/7
24/7 Support

Smart Alerts

Get AI-powered tender recommendations

Market Intel

Track competitor bidding patterns

Email Reports

Weekly detailed analytics reports

Download Hub

Export tender data in bulk format

Smart Tracking

Never miss important deadlines

& Much More...

Discover all premium features with your trial

DS

"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."

Dipanshu Sahijpal • Supernirman
Start 15-Day Free Trial
Secure & Trusted
24/7 Support
Easy Setup

Historical Performance

7-year trend analysis (2018-2025)

Historical Data

Company Overview (1 Apr 2018-31 Mar 2025))

Total Bids

153

Qualified: 74
Q Rate: 48.4%

Contract Value

₹4.21 Cr

Avg. Bid: ₹2.88 Lakh
Avg. EMD: ₹60K

L1 Bids

12

Win Rate: 7.8%
Q to W Ratio: 16.2%

Recent Win Rate

6.7%

Change: +2.4%
Period: FY 2024-25

Performance Analytics

Last 7 Years
Performance Trend
Win/Loss Distribution
Contract Value Growth Over Time

ADORE MEDICAL PRIVATE LIMITED Business Analysis Report: Achieving Success in Government Tenders

This comprehensive business analysis report delves into the performance of ADORE MEDICAL PRIVATE LIMITED in the realm of government tenders. With a focus on financial performance, competitive positioning, and strategic insights, this report aims to provide a clear understanding of the company's strengths, weaknesses, opportunities, and threats within the Indian government procurement landscape. Key highlights include a 7.8% win rate across 153 bids and securing 12 L1 positions, underscoring their potential and existing foothold in the market.

Executive Summary

ADORE MEDICAL PRIVATE LIMITED has demonstrated a strategic presence in the government tender market, participating in 153 tenders with a 7.8% win rate. They have secured 12 L1 positions, showcasing their competitiveness. While their total contract value secured is ₹4,20,66,715.0, analysis reveals areas for improvement in qualification rates and competitive positioning. The company faces challenges with a low win rate and a critical financial health score of 21.2/100. However, there are significant opportunities to optimize bid strategies and capitalize on high-performing quarters to enhance overall performance and financial performance.

Financial Performance of ADORE MEDICAL PRIVATE LIMITED

This section analyzes the financial performance of ADORE MEDICAL PRIVATE LIMITED in securing government contracts, evaluating key metrics such as win rates, contract values, and bidding trends.

Key Financial Metrics

  • Total Bids: 153